Table 3.
Multivariate analysis of overall survival using Cox Proportional Hazard Model.
| Clinico‐pathological variables | Overall survival | ||
|---|---|---|---|
| Hazard ratio | 95% confidence interval | P‐value | |
|
Age Above ≥ 55 years (vs. < 55 years) |
10.41 |
4.19–31.55 |
< 0.0001 |
|
Sex Male (vs. Female) |
1.38 |
0.63–2.86 |
0.4058 |
|
Histology Tall cell variant (vs. other variants) |
2.71 |
1.16–5.93 |
0.0220 |
|
Extrathyroidal extension Present (vs. Absent) |
0.86 |
0.31–2.56 |
0.7815 |
|
pT T3 & T4 (vs. T1 & T2) |
1.68 |
0.57–5.08 |
0.3471 |
|
Lymph node metastasis N1 (vs. N0) |
1.62 |
0.76–3.69 |
0.2183 |
|
Distant metastasis Present (vs. absent) |
3.76 |
1.08–12.30 |
0.0376 |
|
Stage III‐IV (vs. I–II) |
0.92 |
0.26–2.83 |
0.8939 |
|
BRAF mutation Present (vs. Absent) |
0.91 |
0.41–2.19 |
0.8347 |
|
Furin expression High (vs. Low) |
2.43 |
1.09–6.01 |
0.0298 |